Erli Plus XR 25/1000mg Tablet is a combination medication containing two active ingredients: Empagliflozin and Metformin. It is prescribed for the management of type 2 diabetes mellitus to help control blood sugar levels. Empagliflozin belongs to the class of medications called sodium-glucose cotransporter 2 (SGLT2) inhibitors, while Metformin is a biguanide antidiabetic agent.
Uses:
- Type 2 Diabetes Mellitus: Erli Plus XR 25/1000mg Tablet is used to improve glycemic control in adults with type 2 diabetes mellitus. It helps lower blood sugar levels by increasing the removal of glucose through the kidneys and reducing the amount of glucose produced by the liver.
How it Works:
- Empagliflozin: This medication works by inhibiting the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose from the urine back into the bloodstream. By blocking this protein, empagliflozin promotes the excretion of excess glucose in the urine, thereby lowering blood sugar levels.
- Metformin: Metformin works primarily by reducing glucose production in the liver and improving insulin sensitivity in the muscles, allowing them to better utilize glucose for energy. It also helps decrease the absorption of glucose from the intestines.
Dosage and Administration:
- The dosage of Erli Plus XR 25/1000mg Tablet should be individualized based on the patient’s response to treatment, renal function, and other factors.
- It is usually taken orally once daily with a meal to reduce the risk of gastrointestinal side effects.
- Swallow the tablet whole with a glass of water; do not crush, chew, or break it.
Side Effects:
Common side effects of Erli Plus XR 25/1000mg Tablet may include:
- Urinary tract infections
- Increased urination
- Genital yeast infections
- Thirst
- Hypoglycemia (low blood sugar) when used in combination with insulin or sulfonylureas
- Nausea or vomiting
- Diarrhea
- Headache
Serious side effects such as ketoacidosis, dehydration, or allergic reactions are rare but should be reported to a healthcare provider promptly.
Precautions:
- Inform the healthcare provider about any allergies, medical conditions, or medications the patient is currently taking before starting Erli Plus XR 25/1000mg Tablet.
- Use with caution in patients with impaired renal function or a history of urinary tract infections.
- Monitor blood sugar levels regularly as directed by the healthcare provider.
When Not to Use:
Erli Plus XR 25/1000mg Tablet should not be used in patients with:
- Type 1 diabetes mellitus
- Diabetic ketoacidosis
- Severe renal impairment or end-stage renal disease
- Hypersensitivity to empagliflozin, metformin, or any other components of the medication
FAQs:
- How long does it take for Erli Plus XR 25/1000mg Tablet to start working? Improvement in blood sugar levels may be seen within a few weeks of starting treatment. However, it may take several months to achieve optimal glycemic control. Continue taking the medication as prescribed.
- Can Erli Plus XR 25/1000mg Tablet be used alone or in combination with other antidiabetic medications? Erli Plus XR 25/1000mg Tablet can be used alone or in combination with other antidiabetic medications such as insulin or sulfonylureas, depending on the patient’s needs and response to treatment.
- Is it safe to take Erli Plus XR 25/1000mg Tablet during pregnancy or breastfeeding? It is not recommended to use Erli Plus XR 25/1000mg Tablet during pregnancy or breastfeeding. Consult a healthcare provider for alternative treatment options.
- What should I do if I miss a dose of Erli Plus XR 25/1000mg Tablet? If a dose is missed, take it as soon as possible. However, if it is almost time for the next dose, skip the missed dose and resume the regular dosing schedule. Do not double the dose to catch up.
- Can Erli Plus XR 25/1000mg Tablet cause dehydration? Empagliflozin, one of the components of Erli Plus XR 25/1000mg Tablet, can increase urinary excretion of water and electrolytes, leading to dehydration. Ensure adequate fluid intake, especially during hot weather or vigorous exercise.
Reviews
There are no reviews yet.